Current drug shortages

    • What are the most common reasons for drug shortages?

      One main reason for drug shortages, over 60% of the time, involves problems with quality and manufacturing issues. As might be expected, one top reason for drug shortages revolves around quality concerns. According to recent data supplied by FDA, quality issues affect 64% of all drug shortages.


    • What measures can be taken to prevent or reduce drug shortages?

      Development of a long-term strategic action that drug makers can take to help prevent future shortages. FDA is a government regulatory authority that can institute rules to address drugs in short supply, but it cannot force a manufacturer to supply a medication it decides to stop making.


    • What is the current status of drug shortages?

      Hundreds of drug shortages are reported each year. However, the total number of new shortages in 2021, at 114 new products, was the lowest in 10 years. Over 60% of these products were injectables and 24% of medicines were sole source products. Unfortunately, for many drugs, shortages are not resolved from prior years and roll into the next.


    • What is the role of the FDA in managing drug shortages?

      FDA has made a significant impact by taking action on drug shortages and working to improve access. FDA addresses shortages by the following actions: Working with industry to resolve manufacturing issues to allow medications to return to the market.


    • [PDF File]Drug Shortages: 2021 Update (CSAPH 1-N-21) - AMA

      https://info.5y1.org/current-drug-shortages_1_ea3ac5.html

      22 CSAPH has issued eleven 1reports on drug shortages. -11 The findings and conclusions of the first 23 five reports are summarized in CSAPH Report 2-I-15, “National Drug Shortages: Update.” 4. The 24 remainder of this informational report will provide an update on drug shortages since the 2020


    • Report to Congress - U.S. Food and Drug Administration

      This annual report to Congress summarizes the major actions taken by the U.S. Food and Drug Administration (FDA or Agency) during calendar year (CY) 2022 to prevent or mitigate drug shortages1...


    • Drug Shortages for Calendar Year 2021 - U.S. Food and Drug ...

      This annual report to Congress summarizes the major actions taken by the U.S. Food and Drug Administration (FDA or the Agency) during calendar year (CY) 2021 to prevent or mitigate drug...


    • Drug Shortages for Calendar Year 2020 - U.S. Food and Drug ...

      This annual report to Congress summarizes the major actions taken by the U.S. Food and Drug Administration (FDA or the Agency) during calendar year (CY) 2020 to prevent or mitigate drug...


    • Drug Shortage Management - U.S. Food and Drug Administration

      This MAPP establishes CDER’s policy and procedures for notification, evaluation, and management of drug1 shortage situations for all CDER products including those marketed under new drug...


    • Drug Shortages: An Ongoing Crisis and Enduring Solutions

      2019 FDA Task Force Report 9 Current challenges Increased demand –IV narcotics, IV fluids, etc Competition on manufacturing lines and in facilities due to limited capacity and vaccines/related...


Nearby & related entries: